Chronic Lymphocytic Leukemia Clinical Trials in Rochester

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +10 more
2021-12-02
Dec 2, 2021
C
Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • CLR 131 single dose
  • +2 more
  • Redlands, California
  • +14 more
2021-11-30
Nov 30, 2021
N
B
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Washington, District of Columbia
  • +159 more
2021-11-19
Nov 19, 2021
T
Recruiting
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Chicago, Illinois
  • +2 more
2021-11-11
Nov 11, 2021
V
Recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +11 more
2021-11-02
Nov 2, 2021
R
Recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Odronextamab multiple dose levels
  • Orange, California
  • +8 more
2021-10-18
Oct 18, 2021
A
Recruiting
  • Lymphoma, B-Cell
  • +8 more
  • Scottsdale, Arizona
  • +9 more
2021-10-06
Oct 6, 2021
N
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Birmingham, Alabama
  • +873 more
2021-10-08
Oct 8, 2021
A
Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Phoenix, Arizona
  • +30 more
2021-09-23
Sep 23, 2021
L
Recruiting
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Scottsdale, Arizona
  • +55 more
2021-09-17
Sep 17, 2021
A
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Phoenix, Arizona
  • +131 more
2021-08-27
Aug 27, 2021
M
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Scottsdale, Arizona
  • +2 more
2021-08-19
Aug 19, 2021
P
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Post-Chlorambucil Therapy Follow-up
  • +4 more
  • Duarte, California
  • +106 more
2021-08-06
Aug 6, 2021
N
Recruiting
  • Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • Phoenix, Arizona
  • +10 more
2021-07-26
Jul 26, 2021
M
Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +14 more
  • Cholecalciferol
  • Laboratory Biomarker Analysis
  • Scottsdale, Arizona
  • +4 more
2021-04-05
Apr 5, 2021
S
Terminated
  • Chronic Lymphocytic Leukemia
  • +3 more
  • TP-0903
  • TP-0903 and ibrutinib combination therapy
  • Phoenix, Arizona
  • +5 more
2021-01-12
Jan 12, 2021
A
Not yet recruiting
  • Asymptomatic COVID-19 Infection Laboratory-Confirmed
  • +8 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-01-20
Jan 20, 2021
D
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Boston, Massachusetts
  • +3 more
2020-11-30
Nov 30, 2020